1. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer
   Juan M Jiménez-Vacas et al, 2021, The Journal of Clinical Endocrinology & Metabolism CrossRef
2. Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues
   Laura Sophie Tribian et al, 2023, Diagnostics CrossRef
3. Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer
   Liang Kee Goh et al, 2014, PLoS ONE CrossRef
4. Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence
   Mehdi Heidari Horestani et al, 2024, Cell Communication and Signaling CrossRef
5. CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer
   Farzana A. Faisal et al, 2020, Clinical Cancer Research CrossRef
6. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
   Mamello Sekhoacha et al, 2022, Molecules CrossRef
7. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform
   Shira Ronen et al, 2017, Human Pathology CrossRef
8. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines
   Canan Eroğlu et al, 2015, Tumor Biology CrossRef
9. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
   Martina Kluth et al, 2015, Oncotarget CrossRef
10. Nanomedicine for Prostate Cancer Treatment
    Ahmad Mobed et al, 2024, BioNanoScience CrossRef
11. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
    Christoph Burdelski et al, 2017, Oncotarget CrossRef
12. Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma
    XIAOYING WANG et al, 2015, Oncology Letters CrossRef
13. The Cell Cycle and Androgen Signaling Interactions in Prostate Cancer
    Simone de Brot et al, 2018, Precision Molecular Pathology of Prostate Cancer CrossRef
14. Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma
    Khalid Ahmed et al, 2024, Scientific Reports CrossRef
15. miR-24 regulates CDKN1B/p27 expression in prostate cancer
    Seodhna M. Lynch et al, 2016, The Prostate CrossRef
16. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
    James D. Brooks et al, 2015, PLOS ONE CrossRef
17. MIAT inhibits proliferation of cervical cancer cells through regulating miR-150-5p
    Yanbin Liu et al, 2020, Cancer Cell International CrossRef
18. Prostate cancer and the cell cycle: Focusing on the role of microRNAs
    Ibrahim M. Elazab et al, 2024, Gene CrossRef
19. The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy
    Vedran Milosavljevic et al, 2016, PLOS ONE CrossRef
20. The Role of AMACR, CD10, TMPRSS2-ERG, and p27 Protein Expression Among Different Gleason Grades of Prostatic Adenocarcinoma on Needle Biopsy
    Özdemir Gülhan et al, 2020, Clinical Medicine Insights: Oncology CrossRef
21. CIP/KIP and INK4 families as hostages of oncogenic signaling
    Lucia Csergeová et al, 2024, Cell Division CrossRef